Predict which oral white patches may turn cancerous
Part of Cancer, Mouth & dental, Skin clinical trials.
This study looks at oral leukoplakia (persistent white patches in the mouth) to better predict which ones may develop into cancer. It uses a test based on specific immune and cancer-related markers to help estimate each person’s risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 80 and can consent to join
- You have one or more leukoplakia spots in your mouth
- Your leukoplakia may be linked to lichen planus, immune problems, or prior cancers in other body sites
- There is no current evidence that you already have invasive mouth cancer
- You do not have a history of mouth cancer
- You are willing to participate and do not refuse the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with oral lichen planus (a chronic mouth condition) to see how often it turns into mouth cancer. Researchers want to learn more about the condition and what might increase cancer risk.
This study compares two topical treatments for oral leukoplakia, a white patch in the mouth that can become cancer. One treatment uses light-activated therapy (photodynamic therapy), and the other uses a vitamin D cream (calcipotriol).
This study tests whether a cream containing coenzyme Q10 and curcumin can help treat a common mouth condition called oral leukoplakia (a white patch that can sometimes turn into cancer). It is for people with a specific type of white patch that is not severe and can be easily reached with a cream.
This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.
This trial uses artificial intelligence (AI) to help doctors better identify and assess the risk of mouth lesions that could become cancer. If you have a suspicious mouth lesion, this study might help improve early detection and treatment planning.
This trial uses a special light-based scanner (OCT) and artificial intelligence to help diagnose early signs of mouth cancer or precancer. It aims to see if this combination can make diagnosis easier and more accurate.
Hear when a new Oral Leukoplakia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.